Targeting RAF dimers in RAS mutant tumors: From biology to clinic
RAS mutations occur in approximately 30% of tumors worldwide and have a poor prognosis due to limited therapies. Covalent targeting of KRAS G12C has achieved significant success in recent years, but there is still a lack of efficient therapeutic approaches for tumors with non-G12C KRAS mutations. A...
Sparad:
| Huvudupphov: | , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Elsevier
2024-05-01
|
| Serie: | Acta Pharmaceutica Sinica B |
| Ämnen: | |
| Länkar: | http://www.sciencedirect.com/science/article/pii/S221138352400056X |
| Taggar: |
Inga taggar, Lägg till första taggen!
|